BSECompany Update6 Aug 2026 · 6 Aug 2026, 09:56 pm
Audio recording of Earnings Call - Q1 FY27
Emcure Pharmaceuticals Ltd · 544210
✦ AI SummaryResults
Emcure Pharmaceuticals Ltd has made available the audio recording of its Q1 FY27 earnings call on its website.
Analysis Scores
Earnings Impact5/10
Growth Catalyst2/10
Governance Concern1/10
Regulatory Risk1/10
Balance Sheet Risk1/10
Liquidity Impact5/10
Market Sentiment5/10
✦ Ask a Question
Ask anything about this announcement — AI will answer based on the filing content.
Full Announcement
Emcure Pharmaceuticals Ltd - 544210 - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Outcome
Attachments (1)
📄pdf
Download →
49e06a4d-fd64-4e18-8acc-e5ae5b372497.pdf
View document text
Emcure
Ref: EPL/CS/SE/0069/2026 Date: August 06, 2026
National Stock Exchange of India Limited BSE Limited
Exchange Plaza, C-1, Block G, P J Towers,
Bandra Kurla Complex, Bandra (East), Dalal Street,
Mumbai – 400 051 Mumbai - 400 001
Script Symbol: EMCURE Scrip Code/Symbol: 544210/ EMCURE
Dear Sir/Madam,
Subject: Audio recording of Earnings Call – Q1 FY27
Pursuant to Regulation 30 of the Securities and Exchange Board of India (Listing Obligations and
Disclosure Requirements) Regulations, 2015 and further to our intimation dated July 15, 2026
regarding earnings call, the audio recording of the call held today i.e. on August 06, 2026, is
available on our website. The said audio recording can be accessed through the below web
address:
https://www.emcure.com/wp-content/uploads/2026/08/Audio-Q1FY27.mp3
You are requested to take the above information on your records.
Thanking you,
For Emcure Pharmaceuticals Limited
Amruta Yangalwar
Company Secretary & Compliance Officer
ICSI Membership No.: A25687
Emcure Pharmaceuticals Limited
Registered Office: Plot No. P-1 & P-2, IT-BT Park, Phase-II, M.I.D.C., Hinjawadi, Pune - 411057, Maharashtra, India
Phone Nos.: +91 20 – 35070033/ 35070000 Fax No.: +91 20 3507 0060
E-mail: corporate@emcure.com Website: www.emcure.com CIN: L24231PN1981PLC024251